We are building a stronger Business Community in Flemingsberg

We are actively collaborating with key stakeholders to strengthen the innovation ecosystem and promote entrepreneurship in Flemingsberg. A central part of our efforts involves being present alongside other important actors and creating meeting spaces to build close relationships with those who work in the area on a daily basis. We believe that exciting and new opportunities emerge when people come together and exchange ideas.

As part of our Business Community, we recently had the pleasure of inviting Business Sweden to present their latest report, “THE ROAD TO PERSONALISED MEDICINE.” The report highlights the transition to digital health and precision medicine across various markets and emphasizes the business opportunities this development could offer Swedish healthcare companies in Europe. See the interview below with Louise Bengtsson, Senior Consultant at Business Sweden.

Stay updated and sign up for upcoming community events here.

Flemingsberg Science Foundation 2024 – New Opportunities Through Partnerships

As the year comes to an end, it is time to reflect and summarize our progress. We are now concluding year three of our four-year strategic period. Are we moving in the right direction to ensure that Flemingsberg becomes the obvious choice for establishments in southern Stockholm, offering a world-class innovation environment?

Cluster Engine Flemingsberg – ERDF Project for Growth in Life Science

Flemingsberg is taking a significant step towards establishing itself as a central player in Life Science with the launch of the “Cluster Engine Life Science Flemingsberg” project. The project has been granted funding from the European Regional Development Fund and aims to strengthen the growth and establishment of small and medium-sized enterprises (SMEs) within the life science sector in the Stockholm region. The total project budget is €10.8 million for the years 2025–2027.

BioLamina Establishes Operations in Flemingsberg – A Key Player in ATMP Development

As the world’s first and only producer of laminins, the biotechnology company BioLamina has expanded its operations and chosen to establish part of its business in Flemingsberg. Using laminins, a protein that creates an optimal environment for cells to expand and/or differentiate, they are a key player in the development of ATMPs (Advanced Therapy Medicinal Products) in Sweden and globally.

Previous 151617 Next